EPISODE · Jul 18, 2022 · 22 MIN
Treating Breast Cancer with Metformin
from CEimpact Podcast · host CEimpact
Several large observational studies have suggested metformin has anti-tumor effects and may be beneficial as an adjunctive treatment option for breast cancer. This hypothesis was tested by a randomized clinical trial recently published. Listen to host Geoff Wall discuss if metformin is a miracle drug. The GameChanger Metformin can alter insulin signaling which is crucial for the development of certain types of cancer cells. Thus, in various observational and pre-clinical studies, metformin has been associated with better outcomes in breast cancer, usually in patients with diabetes. A recently published RCT found no benefit of taking adjunctive metformin in patients with breast cancer and no diabetes. Show Segments 00:00 – Introductions 01:19 – Metformin in the Treatment of Breast Cancer 02:21 – Insulin Signaling in Tumor Cell Development 06:54 – Effect of Metformin Vs Placebo on Invasive Disease-Free Survival in Patients with Breast Cancer: The MA.32 Randomized Clinical Trial 17:09 – Connecting to Practice & Further Studies 21:17 – The GameChanger 21:55 – Closing Remarks Host Geoff Wall, PharmD, BCPS, FCCP, CGP Professor of Pharmacy Practice, Drake University Internal Medicine/Critical Care, UnityPoint Health References and Resources Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial Redeem your CPE or CME here CPE (Pharmacist) CME (Physician) Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode) Pharmacists: Get a membership Prescribers: Get a membership CE Information Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: Describe the potential mechanism(s) of action of metformin as an anti-tumor agent Discuss the MA.32 study and role of metformin in breast cancer treatment 0.05 CEU/0.5 Hr UAN: 0107-0000-22-248-H01-P Initial release date: 7/18/22 Expiration date: 7/18/23 Additional CPE and CME details can be found here. Follow CEimpact on Social Media:LinkedInInstagram
NOW PLAYING
Treating Breast Cancer with Metformin
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m